Genetic Signatures (ASX:GSS) Days Payable

: 231.19 (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

Genetic Signatures's average Accounts Payable for the six months ended in Dec. 2023 was A$3.22 Mil. Genetic Signatures's Cost of Goods Sold for the six months ended in Dec. 2023 was A$2.54 Mil. Hence, Genetic Signatures's Days Payable for the six months ended in Dec. 2023 was 231.19.

The historical rank and industry rank for Genetic Signatures's Days Payable or its related term are showing as below:

ASX:GSS' s Days Payable Range Over the Past 10 Years
Min: 84.4 Med: 164.04 Max: 360.16
Current: 193.54

During the past 9 years, Genetic Signatures's highest Days Payable was 360.16. The lowest was 84.40. And the median was 164.04.

ASX:GSS's Days Payable is ranked better than
77.62% of 210 companies
in the Medical Diagnostics & Research industry
Industry Median: 68.79 vs ASX:GSS: 193.54

Genetic Signatures's Days Payable increased from Dec. 2022 (134.99) to Dec. 2023 (231.19). It may suggest that Genetic Signatures delayed paying its suppliers.

Genetic Signatures Days Payable Historical Data

The historical data trend for Genetic Signatures's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetic Signatures Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Days Payable

Get a 7-Day Free Trial

119.83

99.37

84.40

93.95

164.04

Genetic Signatures Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Payable	Get a 7-Day Free Trial													70.56	107.20	134.99	180.71	231.19

Competitive Comparison

For the Diagnostics & Research subindustry, Genetic Signatures's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genetic Signatures Days Payable Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Genetic Signatures's Days Payable distribution charts can be found below:

* The bar in red indicates where Genetic Signatures's Days Payable falls into.

Genetic Signatures Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Genetic Signatures's Days Payable for the fiscal year that ended in Jun. 2023 is calculated as

	Days Payable (A: Jun. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Jun. 2022 )	+	Accounts Payable (A: Jun. 2023 ))	/	count )	/	Cost of Goods Sold (A: Jun. 2023 )	*	Days in Period
=	( (3.417	+	3.77)	/	2 )	/	7.996	*	365
=	3.5935					/	7.996	*	365
=	164.04

Genetic Signatures's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (3.77	+	2.673)	/	2 )	/	2.543	*	365 / 2
=	3.2215					/	2.543	*	365 / 2
=	231.19

Genetic Signatures Days Payable Related Terms

Thank you for viewing the detailed overview of Genetic Signatures's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Genetic Signatures (ASX:GSS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetic Signatures Ltd (ASX:GSS) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

7 Eliza Street, Newtown, Sydney, NSW, AUS, 2042

Website

https://www.geneticsignatures.com

Genetic Signatures Ltd proprietary PCR solutions and automated workflows routinely screen for multiple infectious diseases in a single test. Rapid and accurate results facilitate improved patient management and healthcare outcomes. GSS continues to expand its global reach with direct representation in Australia, Europe, and the United States, and growing distribution partnerships. The company operates under one business segment which is the research and commercialisation of identifying individual genetic signatures to diagnose diseases and disabilities.

Genetic Signatures (ASX:GSS) Headlines

No Headlines